India Bans High-Dose Nimesulide Over Safety Concerns

India’s Health Ministry has banned oral Nimesulide doses above 100 mg to protect public health. High doses of this NSAID can cause liver and kidney damage, especially in vulnerable groups. Lower doses remain available, but pharmaceutical companies must recall higher-strength stocks. The move aligns with global safety concerns.